Irbesartan vs Osimertinib
Irbesartan vs Osimertinib: Overview
This comparison examines the pharmacological differences between Irbesartan and Osimertinib.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Irbesartan β 11-15 hours; Osimertinib β 48 hours.
Chemical Properties
Molecular Formula: Irbesartan β C25H28N6O; Osimertinib β C28H33N7O2.
Molecular Weight: Irbesartan β 428.5320 g/mol; Osimertinib β 499.6050 g/mol.
Type: Irbesartan β Small molecule; Osimertinib β Small molecule.